After-Hours Stock Movers

Chegg (NYSE: CHGG) 25% HIGHER; reported Q2 EPS of $0.28, in-line with the analyst estimate of $0.28. Revenue for the quarter came in at $182.85 million versus the consensus estimate of $176.5 million. Total Net Revenues in the range of $151 million to $153 million, versus the consensus of $152.4 million.

Alteryx (NYSE: AYX) 22% LOWER; reported Q2 EPS of ($0.37), $0.30 better than the analyst estimate of ($0.67). Revenue for the quarter came in at $188 million versus the consensus estimate of $182.06 million. Q2 revenue is expected to be in the range of $208 million to $212 million, representing year-over-year decline of (4)% to (2)%, versus the consensus of $233 million. FY23 revenue is expected to be in the range of $930 million to $940 million, representing year-over-year growth of 9% to 10%, versus the consensus of $983.92 million.

Maravai LifeSciences (NASDAQ: MRVI) 11% LOWER; reported Q2 EPS of ($0.05), $0.06 worse than the analyst estimate of $0.01. Revenue for the quarter came in at $68.91 million versus the consensus estimate of $71.13 million.

Beyond Meat (NASDAQ: BYND) 10% LOWER; reported Q2 EPS of ($0.83), $0.01 better than the analyst estimate of ($0.84). Revenue for the quarter came in at $102.1 million versus the consensus estimate of $108.74 million. Beyond Meat sees FY2023 revenue of $360-380 million, versus the consensus of $388 million.

Lucid Group (NASDAQ: LCID) 3% HIGHER; reported Q2 EPS of ($0.40), $0.05 worse than the analyst estimate of ($0.35). Revenue for the quarter came in at $150.9 million versus the consensus estimate of $191.41 million.